Filter
840
Text search:
chemotherapy
Featured
Recommendations
108
New Publications
209
Language
Document type
No document type
427
Studies & Reports
158
Guidelines
145
Manuals
42
Strategic & Response Plan
30
Fact sheets
15
Training Material
11
Situation Updates
5
Online Courses
4
Brochures
1
Dashboards/Maps
1
Infographics
1
Countries / Regions
India
76
Global
41
Kenya
25
South Africa
19
Ethiopia
18
Western and Central Europe
17
Eastern Europe
15
Africa
14
Ghana
10
Uganda
10
Nepal
10
Zambia
9
Tanzania
9
Bangladesh
9
Malawi
9
Nigeria
8
Philippines
8
Botswana
7
Russia
7
Sierra Leone
6
Rwanda
6
Brazil
6
Venezuela
6
Cambodia
5
Indonesia
5
Ukraine
5
Lesotho
5
Myanmar / Burma
5
Latin America and the Carribbean
5
Syria
4
Mozambique
4
Sudan
4
Namibia
4
East and Southern Africa
4
West and Central Africa
4
USA
3
Zimbabwe
3
South Sudan
3
Middle East and North Africa
3
Burkina Faso
2
Congo, Democratic Republic of
2
Saudi Arabia
2
Cameroon
2
Somalia
2
Pakistan
2
Afghanistan
2
Germany
2
Thailand
2
Argentina
2
Eswatini/ Swaziland
2
Ecuador
2
Libya
2
Angola
2
South–East Asia Region
2
Asia
2
Bhutan
2
Southern Africa
2
Laos
2
Qatar
2
Vietnam
2
Liberia
1
Senegal
1
Haiti
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Gambia
1
Benin
1
Colombia
1
Madagascar
1
Yemen
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Palestine
1
Djibouti
1
Timor Leste/ East Timor
1
Iran
1
Australia
1
Georgia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
290
Clinical Guidelines
156
Public Health
50
Women & Child Health
29
Key Resources
18
Pharmacy & Technologies
10
Capacity Building
9
Toolboxes
TB
142
NTDs
105
AMR
63
COVID-19
37
Pharmacy
31
Caregiver
29
HIV
24
Refugee
17
Rapid Response
15
Planetary Health
12
Mental Health
10
Ebola
9
Polio
9
NCDs
9
Conflict
7
Global Health Education
4
Specific Hazards
3
Disability
2
Cholera
2
Natural Hazards
2
Social Ethics
1
Health Financing Toolbox
1
first issued 18 August 2022
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but also for the need to understand the current funding
...
SAMS team rose to meet these challenges, delivering world class COVID treatment with four newly established COVID hospitals complete with 100 ICU beds and state of the art equipment like ventilators, monitors, and oxygen generators. By using innovative technologies, SAMS’ physicians were able to s
...
Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim
...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are
...
Comment reconnaître les maladies tropicales négligées selon les altérations de la peau : guide de formation à l’usage du
personnel sanitaire de première lignes [Recognizing neglected tropical diseases through changes on the skin: a training
guide for front-line health workers]
Guia de treinamento para profissionais de saúde da linha de frente
Versão oficial em português da obra original em Inglês
Recognizing neglected tropical diseases through changes on the skin: a training guide for front-line health workers
Analysis of microfilaria prevalence data from 430 communities
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector
...
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid
...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres
...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan
...
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is an appropriate time to celebrate what has been ach
...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must be a
...
Theodor Bilharz, a German professor of anatomy and chief of surgery at the Kasr El Ani Hospital of Cairo from 1850, first identified an infective organism, Distomum hematobium in 1851, which was renamed Schistosoma haematobium in 1858. It arose from a cestode worm, Hymenoleptis nana, lying in the sm
...
Schistosomiasis is an acute and chronic parasitic disease caused by blood flukes (trematode
worms) of the genus Schistosoma. At least 249 million people required preventive treatment in
2012. Preventive treatment, which should be repeated over a number of years, will reduce and
prevent morbidity.
...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita
...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt
...
